BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 25966434)

  • 1. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
    Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S
    Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment.
    Cholangiocarcinoma Working Group
    Dig Liver Dis; 2020 Dec; 52(12):1430-1442. PubMed ID: 32952071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostics and treatment of cholangiocellular carcinoma].
    Zender L; Malek NP
    Internist (Berl); 2016 Dec; 57(12):1191-1205. PubMed ID: 27822622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma.
    Massironi S; Pilla L; Elvevi A; Longarini R; Rossi RE; Bidoli P; Invernizzi P
    Cells; 2020 Mar; 9(3):. PubMed ID: 32168869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
    Schweitzer N; Vogel A
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
    Wheless M; Agarwal R; Goff L; Lockney N; Padmanabhan C; Heumann T
    Curr Treat Options Oncol; 2024 Jan; 25(1):127-160. PubMed ID: 38177560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and treatment of cholangiocarcinoma.
    Vogel A; Wege H; Caca K; Nashan B; Neumann U
    Dtsch Arztebl Int; 2014 Oct; 111(44):748-54. PubMed ID: 25412632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
    Yao D; Kunam VK; Li X
    J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
    Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
    J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Transplant for Cholangiocarcinoma.
    Zamora-Valdes D; Heimbach JK
    Gastroenterol Clin North Am; 2018 Jun; 47(2):267-280. PubMed ID: 29735023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis, diagnosis, and management of cholangiocarcinoma.
    Ilyas SI; Gores GJ
    Gastroenterology; 2013 Dec; 145(6):1215-29. PubMed ID: 24140396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cholangiocarcinoma.
    Mertens JC; Ilyas SI; Gores GJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1454-1460. PubMed ID: 28844952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostics and treatment of cholangiocarcinoma].
    Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current diagnostic and management options in perihilar cholangiocarcinoma.
    Rizvi S; Gores GJ
    Digestion; 2014; 89(3):216-24. PubMed ID: 24860985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging molecular therapeutic targets for cholangiocarcinoma.
    Ilyas SI; Gores GJ
    J Hepatol; 2017 Sep; 67(3):632-644. PubMed ID: 28389139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personalized treatment of cholangiocellular carcinoma (CCA)].
    Jödicke L; Zender L; Malek NP
    Internist (Berl); 2020 Feb; 61(2):170-174. PubMed ID: 31938815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.